Skip to main content

The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding
through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our full announcement.
  • Guideline Summary
  • NGC:011031
  • 2016

ACR Appropriateness Criteria® acute chest pain — suspected pulmonary embolism.

Kirsch J, Brown RKJ, Henry TS, Javidan-Nejad C, Jokerst C, Julsrud PR, Kanne JP, Kramer CM, Leipsic JA, Panchal KK, Ravenel JG, Shah AB, Mohammed TLH, Woodard PK, Abbara S, Expert Panels on Cardiac and Thoracic Imaging. ACR Appropriateness Criteria® acute chest pain - suspected pulmonary embolism. Reston (VA): American College of Radiology (ACR); 2016. 14 p. [86 references]

View the original guideline documentation External Web Site Policy

This is the current release of the guideline.

This guideline updates a previous version: Bettmann MA, Baginski SG, White RD, Woodard PK, Abbara S, Atalay MK, Dorbala S, Haramati LB, Hendel RC, Martin ET III, Ryan T, Steiner RM, Expert Panel on Cardiac Imaging. ACR Appropriateness Criteria® acute chest pain - suspected pulmonary embolism. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 7 p. [68 references]

This guideline meets NGC's 2013 (revised) inclusion criteria.

UMLS Concepts (what is this?)

SNOMEDCT_US

Major Recommendations

ACR Appropriateness Criteria®

Clinical Condition: Acute Chest Pain–Suspected Pulmonary Embolism

Variant 1: Intermediate probability with a negative D-dimer or low pretest probability.

Radiologic Procedure Rating Comments RRL*
X-ray chest 9   radioactive symbol 1
CTA chest with IV contrast 5 This procedure should be optimized for pulmonary arterial enhancement. This procedure may be appropriate but there was disagreement among panel members on the appropriateness rating as defined by the panel's median rating. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CT chest with IV contrast 3 This procedure should be optimized for pulmonary arterial enhancement. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
US duplex Doppler lower extremity 3 This procedure has a low yield in the absence of symptoms of DVT. O
CT chest without IV contrast 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Tc-99m V/Q scan lung 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CTA chest with IV contrast with CT venography lower extremities 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
MRA chest without and with IV contrast 2   O
US echocardiography transthoracic resting 2   O
CT chest without and with IV contrast 1   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Arteriography pulmonary with right heart catheterization 1   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 radioactive symbol 4
MRA chest without IV contrast 1   O
US echocardiography transesophageal 1   O
Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Intermediate probability with a positive D-dimer or low pretest probability.

Radiologic Procedure Rating Comments RRL*
X-ray chest 9   radioactive symbol 1
CTA chest with IV contrast 9 This procedure should be optimized for pulmonary circulation. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CT chest with IV contrast 9 This procedure should be optimized for pulmonary circulation. This procedure may be an alternative to CTA, but both should not be performed. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Tc-99m V/Q scan lung 7 This procedure may be an alternative to CTA, but both should not be performed. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
US duplex Doppler lower extremity 7 This procedure may be an initial study prior to CTA. O
MRA chest without and with IV contrast 6   O
CTA chest with IV contrast with CT venography lower extremities 5   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Arteriography pulmonary with right heart catheterization 3   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 radioactive symbol 4
US echocardiography transthoracic resting 3   O
CT chest without IV contrast 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CT chest without and with IV contrast 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
MRA chest without IV contrast 2 This procedure has limited sensitivity and may be indicated for rare situations or certain contraindications for a specific patient. O
US echocardiography transesophageal 2   O
Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Pregnant patient.

Radiologic Procedure Rating Comments RRL*
X-ray chest 9   radioactive symbol 1
US duplex Doppler lower extremity 8 This procedure may be an initial examination prior to CTA, which may prevent the need for ionizing radiation in the appropriate clinical setting. O
CTA chest with IV contrast 7 This procedure should be optimized for pulmonary circulation. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CT chest with IV contrast 7 This procedure should be optimized for pulmonary circulation. This procedure may be an alternative to CTA, but both should not be performed. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Tc-99m V/Q scan lung 7 This procedure may be an alternative to CTA, but both should not be performed. Ventilation should be done only if necessary. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
Arteriography pulmonary with right heart catheterization 4 This procedure is rarely indicated. It is used for clarification or catheter-directed intervention. radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 radioactive symbol 4
CTA chest with IV contrast with CT venography lower extremities 3   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
MRA chest without and with IV contrast 3 This procedure may be used as a problem solver or if intervention is planned. There is concern for fetal exposure to contrast. O
MRA chest without IV contrast 3   O
CT chest without IV contrast 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
CT chest without and with IV contrast 2   radioactive symbol 1 radioactive symbol 2 radioactive symbol 3
US echocardiography transesophageal 2   O
US echocardiography transthoracic resting 2   O
Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Summary of Literature Review

Introduction/Background

Over 290,000 cases of fatal pulmonary thromboembolism (PE) and 230,000 cases of nonfatal PE are estimated to occur in the United States each year. Additional cases may not be diagnosed because the symptoms such as chest pain, shortness of breath, and tachycardia are nonspecific and may mimic other pulmonary or cardiac conditions. Unsuspected PE continues to be a frequent autopsy finding.

It has been further estimated that over 80% of PE cases are associated with deep vein thrombosis (DVT). It is, therefore, easy to see why PE, for purposes of diagnosis and treatment, is often considered a complication or a consequence of DVT. A concern with this approach is that some cases of PE are due to embolization from other sites, such as pelvic or upper-extremity veins or the right heart.

Diagnostic efforts in radiology are aimed at: 1) reaching an acceptable level of diagnostic certainty of PE to warrant anticoagulant therapy, using the least invasive tests, and 2) excluding other reasons for the patient's symptoms. Historically, the probability of a patient having PE is typically arrived at using a Bayesian approach in which the pre-test likelihood of the condition (PE), based on clinical and laboratory evidence, is then modified by the results of the appropriate radiological procedure(s) in order to estimate a post-test probability of the condition. This approach has evolved over the last decade. Clinical decision trees, most notably the Wells criteria, have been developed and validated. There have also been major technological advances, primarily in computed tomography (CT) and magnetic resonance imaging (MRI). Many clinical studies have evaluated these modalities and the use of imaging in conjunction with clinical criteria and serum assay for D-dimer. High-sensitivity D-dimer testing using an enzyme-linked immunosorbent assay has improved the specificity of the diagnosis of PE. D-dimer levels will be elevated with any significant thrombotic process, so this test is of limited value in pregnant, postoperative, and trauma patients. It is also of limited value in patients determined to be at high risk of PE by validated clinical criteria. In all other settings a negative D-dimer test effectively excludes PE or DVT.

Overview of Imaging Modalities

Chest Radiography

The posterior anterior and lateral chest radiograph is an important initial study in the evaluation of suspected PE. The chest radiograph may eliminate the need for additional radiographic procedures by revealing an alternate reason for acute symptoms, such as pneumonia or a large effusion. A normal chest radiograph does not exclude PE, and there are no specific findings that are sufficient to confirm PE. A recent chest radiograph is required to allow accurate interpretation of an abnormal radionuclide ventilation/perfusion (V/Q) lung scan.

Computed Tomography

Multidetector CT pulmonary angiography (CTPA) is indicated in the evaluation of patients suspected of having a PE. CTPA is now the primary imaging modality for evaluating patients suspected of having acute PE. CTPA has played an increasingly significant role in the diagnosis of PE since the first major clinical study in 1992. Technological advancements in CT—from helical to multidetector—have led to improved resolution of the pulmonary arteries, large and small. Numerous studies have examined the accuracy of CTPA as compared to V/Q imaging and conventional angiography. Although conventional CT with contrast material (not performed as dedicated CTPA) is generally not indicated in the routine workup of acute chest pain thought to be secondary to acute PE, it should be acknowledged that incidental PE can be accurately diagnosed on routine chest CT with contrast.

It is important to recognize that the increased sensitivity of CT has raised concerns related to evidence of substantial increase in complications from anticoagulation due to the overdiagnosis of PE. However, studies are needed to better determine which small emboli may benefit from treatment and which can go untreated.

For the purposes of distinguishing between CT and CT angiography (CTA), American College of Radiology (ACR) Appropriateness Criteria topics use the definition in the Practice Parameter for the Performance and Interpretation of Body Computed Tomography Angiography (CTA) External Web Site Policy:

"CTA uses a thin-section CT acquisition that is timed to coincide with peak arterial or venous enhancement. The resultant volumetric dataset is interpreted using primary transverse reconstructions as well as multiplanar reformations and 3D renderings."

All elements are essential: 1) timing, 2) reconstructions/reformats, and 3) three-dimensional (3-D) renderings. Standard CTs with contrast also include timing issues and reconstructions/reformats. Only in CTA, however, is 3-D rendering a required element. This corresponds to the definitions that the Centers for Medicare & Medicaid Services have applied to the Current Procedural Terminology codes.

Ventilation and Perfusion Imaging

Since its introduction in the mid-1960s, lung perfusion imaging has been indicated in the workup of patients with suspected PE. The role of lung perfusion imaging for evaluating suspected PE has considerably diminished with the widespread use of CTPA. Still, a normal pattern of regional perfusion in multiple projections accompanied by a normal ventilation scan is widely accepted as indicating that pulmonary emboli are not present and no further workup for PE is necessary.

An abnormal pattern of regional lung perfusion may suggest the diagnosis of PE, but it is not specific. It requires evaluation of the anatomic basis of the perfusion defect (i.e., segmental or not) as well as correlation with other modalities such as ventilation imaging and a recent chest radiograph. These studies are performed to differentiate between reduced pulmonary arterial blood flow due to vascular obstruction and secondary reductions in regional blood flow associated with a variety of airway diseases.

A number of schemes based on various V/Q scan patterns have been developed to assign different probabilities for the presence (or absence) of PE. Generally, V/Q findings are categorized as: "high probability," "intermediate probability" (not meeting the criterion of either "high" or "low"), "low probability," "very low probability," and "normal." All the probability schemes incorporate the results of a recent chest radiograph. At least 1 study suggests that using single photon emission (SPECT) imaging improves the sensitivity and specificity of V/Q scintigraphy.

Ventilation imaging can be performed either before or after technetium-99m (Tc-99m) macroaggregated albumin (MAA) perfusion imaging. Performing a low-dose MAA perfusion scan before the Xe-133 ventilation scan allows the ventilation scan to be obtained in the appropriate projection, rather than the usual posterior projection. In addition, a normal perfusion scan can obviate the need to perform the ventilation scan, thus lowering radiation dose to the patient. Results with Tc-99m-labeled microaerosol agents (diethylenetriamine pentaacetic acid [DTPA], pertechnetate, etc.) are comparable to those of studies using inert gases such as xenon or krypton and have the advantage of providing multiple views for regional V/Q comparisons.

MAA Perfusion Imaging without Ventilation Imaging

MAA perfusion imaging without ventilation may be indicated particularly when the condition of the patient suddenly deteriorates and acute PE is suspected as a significant contributing cause. A demonstration of regions of reduced perfusion, not explained by recent chest radiograph findings, warrants a consideration of PE and possibly the need for further workup such as pulmonary angiography. It may also be indicated in patients who are not candidates for multidetector CTA, such as those who are too large for available CT gantries, who are unable to remain still and hold their breath for the few seconds necessary, or who have severe renal impairment.

Catheter-Directed Selective Pulmonary Angiography

Pulmonary angiography, including right heart catheterization and measurement of pulmonary artery and right heart pressures, is an acceptably safe, albeit invasive, procedure when performed by an experienced operator with adequate patient monitoring. The results may establish the specific diagnosis of PE when an acceptable level of certainty cannot be reached by noninvasive imaging. Given the accuracy of CTPA, however, unacceptably low levels of certainty are increasingly rare. Further, the experience of the radiologist who performs and interprets this invasive procedure is crucial. As indicated, studies suggest that the overall accuracy of catheter pulmonary angiography may be inferior to that of multidetector CTPA, due to technical factors such as patient movement and vessel overlap, as well as inter- and intra-observer variability in interpretation.

The amount of contrast material injected should be limited to that necessary to establish (or exclude) the presence of PE. The number of selective arterial injections may be reduced by focusing on suspicious pulmonary vascular territories indicated by the results of noninvasive V/Q lung scanning. Magnification techniques and imaging in special projection may overcome problems with overlapping vessels.

Ultrasound

Transthoracic echocardiogram (TTE) and transesophageal echocardiogram (TEE) studies are generally not indicated in the diagnosis of acute PE in the setting of acute chest pain. However, these ultrasound (US) procedures are useful in evaluating right ventricular morphology and function that in turn have prognostic implications for morbidity, mortality, and development of future venous thromboembolism.

Magnetic Resonance Angiography, Magnetic Resonance Imaging, and Perfusion Imaging

Magnetic resonance angiography (MRA) and MR perfusion imaging can provide rapid, noninvasive evaluation of the central and segmental pulmonary arteries. Current MRI technology demonstrates high specificity and high sensitivity for proximal PE but still limited sensitivity for distal PE and 30% of inconclusive results. The PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Trial was a multicenter study designed to assess the sensitivity and specificity of MRA, alone or with magnetic resonance venography, for diagnosing PE and venous thromboembolism. It showed that technically adequate MRA had a sensitivity of 78% and a specificity of 99% and that technically adequate MRA and venography had a sensitivity of 92% and a specificity of 96%. It is important to note that the study had a high number of technically inadequate results (up to 52% of patients in the MRA and venography group) and that this varied significantly by clinical center. Due to these findings, the investigators recommended MRA to be considered only at centers that routinely perform it well and only for patients for whom standard tests are contraindicated. A recent study demonstrated that pulmonary MRA studies reach a negative predictive value of up to 97% in patients when followed up clinically for evidence of venous thromboembolism. Just as important, they report 95% of their studies to be of diagnostic quality.

MR perfusion imaging has high sensitivity for PE and is most useful when combined with MRI and MRA.

MRI without MRA is probably not indicated in the routine evaluation of patients with suspected PE. It may rarely be useful in patients who have large central emboli, particularly if used in conjunction with MRI for other indications, such as cardiac morphologic evaluation.

Discussion of the Imaging Modalities by Variant

Variant 1: Intermediate Probability with a Negative D-dimer or Low Pretest Probability

In hemodynamically stable patients with a low or intermediate clinical probability of PE, normal results on D-dimer testing avoid unnecessary further investigation. In such patients, if anticoagulant treatment is not given, the estimated 3-month risk of thromboembolism is 0.14% (95% confidence interval, 0.05–0.41).

In 2011, the National Quality Forum (NQF) endorsed an imaging efficiency measure directed at the appropriateness of CTPA use in emergency department patients. According to NQF measures, imaging was avoidable in 32% of patients, with failure to perform D-dimer testing responsible for nearly two-thirds of potentially avoidable imaging studies. A meta-analysis of 52 studies, comprising 55,268 patients, comparing the test characteristics of gestalt (a physician's unstructured estimate) and clinical decision rules for evaluating adults with suspected PE showed that PE can be safely excluded by a low clinical probability assessment and a negative D-dimer result without the need of imaging.

The PIOPED investigators reported that the combination of a low-probability V/Q scan result and low clinical suspicion reduced the likelihood of PE to <5%. This observation suggests that excluding PE in patients with minimal scan abnormalities and low clinical suspicion for this disorder may be reasonable.

The intermediate pretest probability subgroup may present a more challenging diagnostic enigma. For these patients D-dimer testing is warranted. Recent studies have demonstrated that a normal high-sensitivity D-dimer level can be used to further risk-stratify patients at both low and intermediate risk for PE. Another study enrolled 674 non–high-risk patients (at either low or intermediate risk for PE). Those with normal D-dimer levels were followed for 3 months and no thromboembolic events were noted. One study used the Wells criteria, and another used the revised Geneva score. They evaluated 1679 and 330 patients, respectively, who were determined to be at intermediate risk for PE and found that a normal D-dimer level was 99.5% and 100% sensitive, respectively, for excluding PE on CT. A negative result from a high-sensitivity D-dimer test in patients with either low or intermediate probability safely excludes PE without the need for further imaging.

Variant 2: Intermediate Probability with a Positive D-dimer or High Pretest Probability

Multiple studies have shown that CTPA is highly sensitive and specific; discrepancies with conventional angiography are mainly at the subsegmental level where even angiographers tend to have poor interobserver agreement. Intraobserver and interobserver variability for CTPA have been shown to be very good to the segmental level, better than with V/Q imaging.

The overall accuracy of CTPA appears to be very high and is even higher when combined with clinical assessment and serum D-dimer testing. A positive CTPA result combined with high or intermediate suspicion on clinical assessment has a high positive predictive value. In addition, the adjunctive use of CT venography with CTPA improves the sensitivity of detecting DVT, with similar specificity, thereby increasing the overall accuracy of the diagnosis of thromboembolic disease, as compared to an isolated diagnosis of PE.

CTPA also has fewer "nondiagnostic" studies than V/Q scans. The false-negative rate of CTPA is very low. Outcome studies have shown no adverse outcomes in patients with a negative CTPA who were not subsequently treated. Another study has shown CTPA to be cost effective in conjunction with lower-extremity duplex examinations. The combination of multidetector CTPA and high-specificity D-dimer testing has very high positive and negative predictive values. In addition, CTPA may occasionally demonstrate pathology other than PE that may be responsible for the patient's symptoms.

CTPA can also identify signs of right ventricular dysfunction that may have prognostic significance or implications for treatment (e.g., need for the institution of thrombolytic therapy versus conventional anticoagulation alone). Measurements of right ventricular enlargement and reflux of contrast to the inferior vena cava have been used among other indexes to gauge right ventricular dysfunction and predict patient mortality. Recent technological advancements such as electrocardiogram-gated CT and dual-source CT have allowed accurate evaluation of the pulmonary vasculature, thoracic aorta, and coronary arteries on a single CT study. This so-called triple rule-out CT protocol has been shown to be feasible, although it has yet to be proven useful or cost effective through large-scale clinical trials.

In general, the data indicate that multidetector CTPA is more sensitive than single-slice CT or other studies, such as V/Q scans. Studies have shown that the high resolution of CTPA makes it possible to detect filling defects in distal subsegmental arteries as small as 2 to 3 mm in diameter. Only 1% of V/Q scans rated as "high probability" correspond to an isolated subsegmental PE, compared with 15% of positive CTPA scans. However, these distal very small clots remain of indeterminate clinical significance and some of them may not require treatment.

The general indications for pulmonary catheter angiography in the past have included: a) cases with "low probability" or "intermediate probability" V/Q scan findings, particularly when there is a high clinical suspicion for PE, and anticoagulation is considered risky or relatively contraindicated; b) when pulmonary thromboendarterectomy or thrombolysis is considered (e.g., chronic pulmonary hypertension secondary to major vessel thromboembolic occlusion or symptomatic massive or submassive PE that may require catheter-directed therapy); and c) before placement of an inferior vena cava filter. Because multidetector CTPA is currently the standard of care for PE detection, there are now far fewer cases in which catheter pulmonary angiography is indicated or necessary, and these are now largely confined to situations in which catheter-directed thrombectomy or thrombolysis is thought to be clinically indicated.

Because of the high association of DVT with PE, US evaluation of the venous drainage of the lower extremities may be indicated, especially in patients with signs and symptoms of DVT. US studies include duplex Doppler with leg compression and continuous-wave Doppler. The presence of DVT does not indicate the presence of PE but increases its likelihood. Also, positive DVT studies may identify patients at higher risk for subsequent PE. In most patients, however, the presence of DVT—whether or not associated with PE—has identical treatment, so no further diagnostic evaluation for PE is needed. A negative extremity US study does not exclude PE, although it significantly decreases its likelihood. For a more detailed discussion on DVT, refer to the NGC summary of the ACR Appropriateness Criteria® suspected lower-extremity deep vein thrombosis.

Variant 3: Pregnant Patient

PE is a leading cause of pregnancy-related mortality in the developed world, accounting for 20% of maternal deaths in the United States. The American Thoracic Society/Society of Thoracic Radiology (ATS/STR) Committee on Pulmonary Embolism in Pregnancy published their Clinical Practice Guideline—Evaluation of Suspected Pulmonary Embolism in Pregnancy, summarized in 7 recommendations that put a high value on avoiding workup with radiation-associated tests if possible. Lower-extremity duplex ultrasonography for assessment of DVT was recommended in pregnant patients with suspected PE and signs and symptoms of lower extremity DVT as a means of determining the presence of thrombosis suggestive of pulmonary thromboembolism without radiation.

The modality of choice (CTPA versus V/Q scan) in pregnant patients remains a matter of debate. Fetal radiation doses delivered in utero by properly performed diagnostic tests present no measurably increased risk of prenatal death, malformation, or impairment of mental development over the background incidence of these entities. The ATS/STR statement recommends scintigraphy over CTA mainly over maternal, not fetal, radiation dose concerns.

When lung scans are indicated in pregnant women, the administered dose of the radiopharmaceutical(s) should be reduced by a factor of 2 or more, with correspondingly longer acquisition times to achieve adequate imaging statistics. Doing so may minimize absorbed radiation dose. If the MAA perfusion scan is performed first and is normal, the ventilation scan can be avoided.

A follow-up MAA perfusion scan may be recommended 6 to 8 weeks after the discovery of a "mismatched" V/Q pattern (presumption of PE). Failure of observed resolution, or of at least significant improvement in regional perfusion, may signal the development of pulmonary hypertension secondary to chronic thromboembolic obstruction in the major pulmonary vessels. This complication has an expected incidence of <1%. Caution should be exercised in interpreting perfusion imaging in the days after acute PE because reestablishment of regional perfusion (resolution of defects) occurs at varying and unpredictable rates. Conversely, local ventilation may be compromised for minutes to hours after an acute PE.

The use of pulmonary MR angiography is also of at least theoretical value in pregnant patients, as well as patients in whom the use of iodinated contrast agents is contraindicated. Although there are no studies to date suggesting that there is risk to a developing fetus, there is also no proof that the use of gadolinium-containing contrast agents is safe. They should, therefore, be used only when clearly indicated.

Summary of Recommendations

  • Variant 1
    • In patients with low or intermediate clinical probability of PE, normal results on D-dimer testing avoid unnecessary further investigation.
  • Variant 2
    • CTPA is highly sensitive and specific.
    • CTPA also has fewer "nondiagnostic" studies than V/Q scans.
    • There is a high association of DVT with PE; therefore, US evaluation of the venous drainage of the lower extremities may be indicated, especially in patients with signs and symptoms of DVT.
  • Variant 3
    • Workup with radiation-associated tests should be avoided if possible.
    • Lower-extremity duplex ultrasonography for assessment of DVT is recommended in pregnant patients with suspected PE and signs and symptoms of lower-extremity DVT.
    • There is still some debate over the preference of CTPA or scintigraphy.

Anticipated Exceptions

If multidetector CTPA is not available, then V/Q scans, pulmonary MRA, and/or lower-extremity US may need to be used for evaluation. The choice between CTPA and V/Q scanning in pregnant patients remains unresolved. With careful, modern techniques, both are acceptable. The radiation dose to the fetus, in general, is probably lower with V/Q scanning, although dose-modulation techniques with CT may make the 2 modalities nearly equivalent in absorbed dose. If a chest radiograph is abnormal, CTPA has a higher likelihood of being definitive.

Abbreviations

  • CT, computed tomography
  • CTA, CT angiography
  • DVT, deep vein thrombosis
  • IV, intravenous
  • MRA, magnetic resonance angiography
  • Tc-99m, technetium-99 metastable
  • US, ultrasound
  • V/Q, ventilation/perfusion

Relative Radiation Level Designations

Relative Radiation Level* Adult Effective Dose Estimate Range Pediatric Effective Dose Estimate Range
O 0 mSv 0 mSv
radioactive symbol 1 <0.1 mSv <0.03 mSv
radioactive symbol 1 radioactive symbol 2 0.1-1 mSv 0.03-0.3 mSv
radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 1-10 mSv 0.3-3 mSv
radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 radioactive symbol 4 10-30 mSv 3-10 mSv
radioactive symbol 1 radioactive symbol 2 radioactive symbol 3 radioactive symbol 4 radioactive symbol 5 30-100 mSv 10-30 mSv
*RRL assignments for some of the examinations cannot be made, because the actual patient doses in these procedures vary as a function of a number of factors (e.g., region of the body exposed to ionizing radiation, the imaging guidance that is used). The RRLs for these examinations are designated as "Varies."

Clinical Algorithm(s)

Algorithms were not developed from criteria guidelines.

Disease/Condition(s)

  • Acute chest pain
  • Suspected pulmonary embolism

Guideline Category

Diagnosis

Evaluation

Clinical Specialty

Cardiology

Critical Care

Emergency Medicine

Family Practice

Internal Medicine

Nuclear Medicine

Obstetrics and Gynecology

Pulmonary Medicine

Radiology

Intended Users

Advanced Practice Nurses

Health Plans

Hospitals

Managed Care Organizations

Physician Assistants

Physicians

Students

Utilization Management

Guideline Objective(s)

To evaluate the appropriateness of imaging procedures for patients with acute chest pain and suspected pulmonary embolism

Target Population

Patients with acute chest pain and suspected pulmonary embolism, including pregnant patients

Interventions and Practices Considered

  1. X-ray, chest
  2. Computed tomography (CT), chest
    • With intravenous (IV) contrast
    • Without IV contrast
    • Without and with IV contrast
  3. CT angiography (CTA), chest
    • With IV contrast
    • With IV contrast, with CT venography, lower extremities
  4. Ultrasound (US)
    • Duplex Doppler, lower extremity
    • Echocardiography, transesophageal (TEE)
    • Echocardiography, transthoracic (TTE) resting
  5. Tc-99m ventilation/perfusion (V/Q) scan, lung
  6. Pulmonary arteriography with right heart catheterization
  7. Magnetic resonance angiography (MRA), chest
    • Without and with IV contrast
    • Without IV contrast

Major Outcomes Considered

  • Utility of imaging modalities in differential diagnosis
  • Sensitivity, specificity, and positive/negative predictive value of diagnostic tests

Methods Used to Collect/Select the Evidence

Hand-searches of Published Literature (Primary Sources)

Hand-searches of Published Literature (Secondary Sources)

Searches of Electronic Databases

Description of Methods Used to Collect/Select the Evidence

Literature Search Summary

Of the 68 citations in the original bibliography, 64 were retained in the final document. Articles were removed from the original bibliography if they were more than 10 years old and did not contribute to the evidence or they were no longer cited in the revised narrative text.

A new literature search was conducted in July 2013 and updated in May 2015 to identify additional evidence published since the ACR Appropriateness Criteria® Acute Chest Pain-Suspected Pulmonary Embolism topic was finalized. Using the search strategies described in the literature search companion (see the "Availability of Companion Documents" field), 594 articles were found. Four articles were added to the bibliography. Five hundred ninety articles were not used due to either poor study design, the articles were not relevant or generalizable to the topic, the results were unclear, misinterpreted, or biased, or the articles were already cited in the original bibliography.

The author added 12 citations from bibliographies, Web sites, or books that were not found in the new literature search.

Six citations are supporting documents that were added by staff.

See also the American College of Radiology (ACR) Appropriateness Criteria® literature search process document (see the "Availability of Companion Documents" field) for further information.

Number of Source Documents

Of the 68 citations in the original bibliography, 64 were retained in the final document. The new literature search conducted in July 2013 and updated in May 2015 identified 4 articles that were added to the bibliography. The author added 12 citations from bibliographies, Web sites, or books that were not found in the new literature search. Six citations are supporting documents that were added by staff.

Methods Used to Assess the Quality and Strength of the Evidence

Weighting According to a Rating Scheme (Scheme Given)

Rating Scheme for the Strength of the Evidence

Definitions of Study Quality Categories

Category 1 - The study is well-designed and accounts for common biases.

Category 2 - The study is moderately well-designed and accounts for most common biases.

Category 3 - The study has important study design limitations.

Category 4 - The study or source is not useful as primary evidence. The article may not be a clinical study, the study design is invalid, or conclusions are based on expert consensus.

The study does not meet the criteria for or is not a hypothesis-based clinical study (e.g., a book chapter or case report or case series description);

Or

The study may synthesize and draw conclusions about several studies such as a literature review article or book chapter but is not primary evidence;

Or

The study is an expert opinion or consensus document.

Category M - Meta-analysis studies are not rated for study quality using the study element method because the method is designed to evaluate individual studies only. An "M" for the study quality will indicate that the study quality has not been evaluated for the meta-analysis study.

Methods Used to Analyze the Evidence

Review of Published Meta-Analyses

Systematic Review with Evidence Tables

Description of the Methods Used to Analyze the Evidence

The topic author assesses the literature then drafts or revises the narrative summarizing the evidence found in the literature. American College of Radiology (ACR) staff drafts an evidence table based on the analysis of the selected literature. These tables rate the study quality for each article included in the narrative.

The expert panel reviews the narrative, evidence table and the supporting literature for each of the topic-variant combinations and assigns an appropriateness rating for each procedure listed in the variant table(s). Each individual panel member assigns a rating based on his/her interpretation of the available evidence.

More information about the evidence table development process can be found in the ACR Appropriateness Criteria® Evidence Table Development document (see the "Availability of Companion Documents" field).

Methods Used to Formulate the Recommendations

Expert Consensus (Delphi)

Description of Methods Used to Formulate the Recommendations

Rating Appropriateness

The American College of Radiology (ACR) Appropriateness Criteria (AC) methodology is based on the RAND Appropriateness Method. The appropriateness ratings for each of the procedures or treatments included in the AC topics are determined using a modified Delphi method. A series of surveys are conducted to elicit each panelist's expert interpretation of the evidence, based on the available data, regarding the appropriateness of an imaging or therapeutic procedure for a specific clinical scenario. The expert panel members review the evidence presented and assess the risks or harms of doing the procedure balanced with the benefits of performing the procedure. The direct or indirect costs of a procedure are not considered as a risk or harm when determining appropriateness. When the evidence for a specific topic and variant is uncertain or incomplete, expert opinion may supplement the available evidence or may be the sole source for assessing the appropriateness.

The appropriateness is represented on an ordinal scale that uses integers from 1 to 9 grouped into three categories: 1, 2, or 3 are in the category "usually not appropriate" where the harms of doing the procedure outweigh the benefits; and 7, 8, or 9 are in the category "usually appropriate" where the benefits of doing a procedure outweigh the harms or risks. The middle category, designated "may be appropriate," is represented by 4, 5, or 6 on the scale. The middle category is when the risks and benefits are equivocal or unclear, the dispersion of the individual ratings from the group median rating is too large (i.e., disagreement), the evidence is contradictory or unclear, or there are special circumstances or subpopulations which could influence the risks or benefits that are embedded in the variant.

The ratings assigned by each panel member are presented in a table displaying the frequency distribution of the ratings without identifying which members provided any particular rating. To determine the panel's recommendation, the rating category that contains the median group rating without disagreement is selected. This may be determined after either the first or second rating round. If there is disagreement after the second rating round, the recommendation is "May be appropriate."

This modified Delphi method enables each panelist to articulate his or her individual interpretations of the evidence or expert opinion without excessive influence from fellow panelists in a simple, standardized, and economical process. For additional information on the ratings process see the Rating Round Information External Web Site Policy document.

Additional methodology documents, including a more detailed explanation of the complete topic development process and all ACR AC topics can be found on the ACR Web site External Web Site Policy (see also the "Availability of Companion Documents" field).

Rating Scheme for the Strength of the Recommendations

Not applicable

Cost Analysis

One study has shown computed tomography pulmonary angiography (CTPA) to be cost effective in conjunction with lower-extremity duplex examinations. The so-called triple rule-out CT protocol has been shown to be feasible, although it has yet to be proven useful or cost effective through large-scale clinical trials.

Method of Guideline Validation

Internal Peer Review

Description of Method of Guideline Validation

Criteria developed by the Expert Panels are reviewed by the American College of Radiology (ACR) Committee on Appropriateness Criteria.

Type of Evidence Supporting the Recommendations

The recommendations are based on analysis of the current medical evidence literature and the application of the RAND/UCLA appropriateness method and expert panel consensus.

Summary of Evidence

Of the 86 references cited in the ACR Appropriateness Criteria® Acute Chest Pain-Suspected Pulmonary Embolism document, all of them are categorized as diagnostic references including 11 well designed studies, 15 good quality studies, and 27 quality studies that may have design limitations. There are 31 references that may not be useful as primary evidence. There are 2 references that are meta-analysis studies.

While there are references that report on studies with design limitations, 26 well designed or good quality studies provide good evidence.

Potential Benefits

Diagnostic efforts in radiology are aimed at reaching an acceptable level of diagnostic certainty of pulmonary embolism (PE) to warrant anticoagulant therapy, using the least-invasive tests and excluding other reasons for the patient's symptoms.

Potential Harms

  • Caution should be exercised in interpreting perfusion imaging in the days after acute pulmonary embolism (PE), because reestablishment of regional perfusion (resolution of defects) occurs at varying and unpredictable rates. Conversely, local ventilation may be compromised for minutes to hours after an acute PE.
  • It is important to recognize that the increased sensitivity of computed tomography (CT) has raised concerns related to evidence of substantial increase in complications from anticoagulation due to the overdiagnosis of PE.

Safety Considerations in Pregnant Patients

Imaging of the pregnant patient can be challenging, particularly with respect to minimizing radiation exposure and risk. For further information and guidance, see the following American College of Radiology (ACR) documents:

Relative Radiation Level Information

Potential adverse health effects associated with radiation exposure are an important factor to consider when selecting the appropriate imaging procedure. Because there is a wide range of radiation exposures associated with different diagnostic procedures, a relative radiation level (RRL) indication has been included for each imaging examination. The RRLs are based on effective dose, which is a radiation dose quantity that is used to estimate population total radiation risk associated with an imaging procedure. Patients in the pediatric age group are at inherently higher risk from exposure, both because of organ sensitivity and longer life expectancy (relevant to the long latency that appears to accompany radiation exposure). For these reasons, the RRL dose estimate ranges for pediatric examinations are lower as compared to those specified for adults. Additional information regarding radiation dose assessment for imaging examinations can be found in the ACR Appropriateness Criteria® Radiation Dose Assessment Introduction document (see the "Availability of Companion Documents" field).

Qualifying Statements

  • The American College of Radiology (ACR) Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physicians in making decisions regarding radiologic imaging and treatment. Generally, the complexity and severity of a patient's clinical condition should dictate the selection of appropriate imaging procedures or treatments. Only those examinations generally used for evaluation of the patient's condition are ranked. Other imaging studies necessary to evaluate other co-existent diseases or other medical consequences of this condition are not considered in this document. The availability of equipment or personnel may influence the selection of appropriate imaging procedures or treatments. Imaging techniques classified as investigational by the U.S. Food and Drug Administration (FDA) have not been considered in developing these criteria; however, study of new equipment and applications should be encouraged. The ultimate decision regarding the appropriateness of any specific radiologic examination or treatment must be made by the referring physician and radiologist in light of all the circumstances presented in an individual examination.
  • ACR seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply individual or society endorsement of the final document.

Description of Implementation Strategy

An implementation strategy was not provided.

IOM Care Need

Getting Better

IOM Domain

Effectiveness

Bibliographic Source(s)

Kirsch J, Brown RKJ, Henry TS, Javidan-Nejad C, Jokerst C, Julsrud PR, Kanne JP, Kramer CM, Leipsic JA, Panchal KK, Ravenel JG, Shah AB, Mohammed TLH, Woodard PK, Abbara S, Expert Panels on Cardiac and Thoracic Imaging. ACR Appropriateness Criteria® acute chest pain - suspected pulmonary embolism. Reston (VA): American College of Radiology (ACR); 2016. 14 p. [86 references]

Adaptation

Not applicable: The guideline was not adapted from another source.

Date Released

2016

Guideline Developer(s)

American College of Radiology - Medical Specialty Society

Source(s) of Funding

The American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

Guideline Committee

Committee on Appropriateness Criteria, Expert Panels on Cardiac and Thoracic Imaging

Composition of Group That Authored the Guideline

Panel Members: Jacobo Kirsch, MD (Principal Author); Richard K. J. Brown, MD; Travis S. Henry, MD; Cylen Javidan-Nejad, MD; Clinton Jokerst, MD; Paul R. Julsrud, MD; Jeffrey P. Kanne, MD; Christopher M. Kramer, MD; Jonathon A. Leipsic, MD; Kalpesh K. Panchal, MD; James G. Ravenel, MD; Amar B. Shah, MD; Tan-Lucien H. Mohammed, MD (Specialty Chair); Pamela K. Woodard, MD (Specialty Chair); Suhny Abbara, MD (Panel Chair)

Financial Disclosures/Conflicts of Interest

Not stated

Guideline Status

This is the current release of the guideline.

This guideline updates a previous version: Bettmann MA, Baginski SG, White RD, Woodard PK, Abbara S, Atalay MK, Dorbala S, Haramati LB, Hendel RC, Martin ET III, Ryan T, Steiner RM, Expert Panel on Cardiac Imaging. ACR Appropriateness Criteria® acute chest pain - suspected pulmonary embolism. [online publication]. Reston (VA): American College of Radiology (ACR); 2011. 7 p. [68 references]

This guideline meets NGC's 2013 (revised) inclusion criteria.

Guideline Availability

Availability of Companion Documents

The following are available:

  • ACR Appropriateness Criteria®. Overview. Reston (VA): American College of Radiology; 2015 Oct. 3 p. Available from the American College of Radiology (ACR) Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Literature search process. Reston (VA): American College of Radiology; 2015 Feb. 1 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Evidence table development. Reston (VA): American College of Radiology; 2015 Nov. 5 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Topic development process. Reston (VA): American College of Radiology; 2015 Nov. 2 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Rating round information. Reston (VA): American College of Radiology; 2015 Apr. 5 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Radiation dose assessment introduction. Reston (VA): American College of Radiology; 2015 Sep. 3 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Manual on contrast media. Reston (VA): American College of Radiology; 2016. 128 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria®. Procedure information. Reston (VA): American College of Radiology; 2016 May. 2 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria® acute chest pain — suspected pulmonary embolism. Evidence table. Reston (VA): American College of Radiology; 2016. 29 p. Available from the ACR Web site External Web Site Policy.
  • ACR Appropriateness Criteria® acute chest pain — suspected pulmonary embolism. Literature search. Reston (VA): American College of Radiology; 2016. 2 p. Available from the ACR Web site External Web Site Policy.

Patient Resources

None available

NGC Status

This NGC summary was completed by ECRI on February 20, 2001. The information was verified by the guideline developer on March 14, 2001. This summary was updated by ECRI Institute on April 25, 2007. This summary was updated by ECRI Institute on February 7, 2012 and on September 14, 2016.

Copyright Statement

Instructions for downloading, use, and reproduction of the American College of Radiology (ACR) Appropriateness Criteria® may be found on the ACR Web site External Web Site Policy.

NGC Disclaimer

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria.

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.